BRIEF published on 12/03/2024 at 14:34, 1 year 11 months ago Eckert & Ziegler annonce des changements au sein de son conseil d'administration et de son conseil de surveillance Eckert & Ziegler Conseil De Surveillance Conseil Exécutif Jutta Ludwig Dr Gunnar Mann
PRESS RELEASE published on 12/03/2024 at 14:29, 1 year 11 months ago Eckert & Ziegler: Changes in the Executive Board and Supervisory Board Eckert & Ziegler SE appoints Dr. Gunnar Mann to Executive Board and welcomes changes in Supervisory Board. Dr. Mann to lead Medical segment Executive Board Supervisory Board Eckert & Ziegler SE Medical Segment Dr. Gunnar Mann
BRIEF published on 12/02/2024 at 09:05, 1 year 11 months ago Eckert & Ziegler Initiates Actinium-225 Production to Tackle Global Shortage Nuclear Medicine Radiopharmaceuticals Actinium-225 Production Isotope Supply GMP Certification
BRIEF published on 12/02/2024 at 09:05, 1 year 11 months ago Eckert & Ziegler lance la production d'actinium 225 pour faire face à la pénurie mondiale Produits Radiopharmaceutiques Médecine Nucléaire Production D'actinium 225 Approvisionnement En Isotopes Certification GMP
PRESS RELEASE published on 12/02/2024 at 09:00, 1 year 11 months ago Eckert & Ziegler Begins Production of Actinium-225, Paving the Way for GMP-Grade Supply Eckert & Ziegler starts Actinium-225 production in collaboration with Czech Academy of Sciences, aiming for GMP-grade supply to boost alpha-emitting radiopharmaceuticals development Eckert & Ziegler Production Radiopharmaceuticals Actinium-225 GMP-grade
BRIEF published on 11/27/2024 at 09:05, 1 year 11 months ago Eckert & Ziegler Gains European Approval for Theralugand® Cancer Therapy Radiopharmaceuticals Lutetium-177 European Approval Theralugand®
BRIEF published on 11/27/2024 at 09:05, 1 year 11 months ago Eckert & Ziegler obtient l'approbation européenne pour Theralugand® Produits Radiopharmaceutiques Thérapie Contre Le Cancer Lutetium-177 Theralugand® Agrément Européen
PRESS RELEASE published on 11/27/2024 at 09:00, 1 year 11 months ago Eckert & Ziegler Achieves European Approval for Theralugand® - Lutetium-177 Chloride (n.c.a) Eckert & Ziegler receives EC approval for Theralugand® - Lutetium-177 Chloride, expanding cancer therapy options in Europe Eckert & Ziegler Cancer Therapy EC Approval Theralugand Lutetium-177 Chloride
BRIEF published on 11/22/2024 at 15:32, 1 year 11 months ago Eckert & Ziegler Increases 2024 Financial Forecast Eckert & Ziegler Sales Increase Financial Forecast EBIT Growth 2024 Business
BRIEF published on 11/22/2024 at 15:32, 1 year 11 months ago Eckert & Ziegler augmente ses prévisions financières pour 2024 Eckert & Ziegler Prévisions Financières Augmentation Des Ventes Croissance Du Résultat D'exploitation (EBIT) Entreprise 2024
Published on 11/06/2026 at 22:15, 4 hours 31 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 13 hours 46 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 14 hours 16 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 14 hours 16 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 20:15, 6 hours 31 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 6 hours 31 minutes ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 7 hours 30 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 7 hours 46 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 8 hours 13 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 19:06, 7 hours 39 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 7 hours 41 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 7 hours 44 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 7 hours 46 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
